Hansa Biopharma to Participate in Three Upcoming Investor Conferences

LUND, Sweden, Aug. 21, 2019 /PRNewswire/ -- Hansa Biopharma, the leader in immunomodulatory enzyme technology for rare IgG-mediated diseases, announced today that the Company's management team will participate in the following upcoming investor conferences:

• The Goldman Sachs Ninth Annual Biotech Symposium in London on Friday, September 6, 2019.
• The Morgan Stanley 17th Annual Global Healthcare Conference in New York City, NY Tuesday, September 10, 2019, with a presentation at 1:30 PM EST/ 19:30 CET on the same day.
• The Bank of America Merrill Lynch Global Healthcare Conference 2019 in London from Thursday, September 19, 2019 to Friday, September 20, 2019, with a presentation at 14:45 CET on Friday September 20.

A live webcast of the Morgan Stanley presentation will be available on the Events & Webcast page of the Company's website, www.hansabiopharma.com. A replay of the presentation will be available approximately two hours after the event and will be available for two weeks following the presentation.

CONTACT:
Klaus Sindahl, Head of Investor Relations
Hansa Biopharma 
Mobile: +46 (0) 709-298 269
E-mail: klaus.sindahl@hansabiopharma.com 

Rolf Gulliksen, Head of Corporate Communications
Hansa Biopharma
Mobile: +46 (0) 733-328 634
E-mail: rolf.gulliksen@hansabiopharma.com 

This information was brought to you by Cision http://news.cision.com 
https://news.cision.com/hansa-biopharma-ab/r/hansa-biopharma-to-participate-in-three-upcoming-investor-conferences,c2884759

The following files are available for download:

View original content:http://www.prnewswire.com/news-releases/hansa-biopharma-to-participate-in-three-upcoming-investor-conferences-300904967.html

SOURCE Hansa Biopharma AB